Trial intelligence / Profile preview

Postoperative Analgesic Effect of Orally Administrated Nefopam After a Total Knee Arthroplasty

NCT04576078Phase 2Recruiting

Sponsor
Hospices Civils de Lyon
Start
Jun 2021
Primary completion
Dec 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in postoperative pain comparing NEFOPAM 60mg PO/ 8 hours with Placebo (2 arms). Primary endpoint: Total morphine consumption at 24 hours. Started Jun 2021; status: recruiting.

02

Drugs

nefopam
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04576078.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04576078.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call